Global Dialysis Market Report Forecast By Type (Peritoneal Dialysis, Hemodialysis), Product & Services (Services, Equipment, Consumables, Drugs), End User (Home Dialysis, In Center Dialysis), Countries and Company Analysis 2024-2032

Driving Forces of Dialysis Market

Increasing Propensity for Chronic Kidney Diseases to Support Market Expansion

One of the main drivers fueling market's growth is the upsurge in the prevalence of renal failure and chronic kidney diseases, as well as the growing comorbidity of diabetes and hypertension in patients. When a patient reaches end-stage renal disease (ESRD), either a kidney transplant or long-term renal infusion therapy is required to keep one or both kidneys functionally intact. Thus, the rising prevalence of ESRD is increasing the global cost burden of kidney diseases and is one of the key factors increasing the revenue of leading market players.

For instance, about 786,000 Americans had end-stage renal disease (ESRD) in September 2021; of those, 71% were receiving dialysis, according to data from the NIDDKD (National Institute of Diabetes and Digestive and Kidney Diseases). Similarly, almost 4.8 million people worldwide had chronic renal failure in 2022, according to Fresenius Medical Care's 2022 annual report. It is anticipated that this figure will rise by 3-6% year. Furthermore, As per the 25th Annual Report of the U.K. Renal Registry, the overall prevalence of chronic kidney disease (CKD) in the United Kingdom in 2021 was 1,176 per million population (pmp). In 2021, there were 21,334 prevalent population counts in the country.

Enlargement of private dialysis clinics and centers

The industry is being supported by the growth of private dialysis clinics and facilities. These private facilities have a number of significant benefits that support their influence on market expansion. Private clinics frequently offer specialised, individualised care that is catered to each patient's particular requirements. This degree of personalisation improves patient outcomes and happiness, drawing in more customers and increasing market demand. Additionally, patients' tastes and habits are typically accommodated by the more flexible scheduling possibilities offered by private dialysis centres. This convenience feature draws those who are looking for therapies that fit into their hectic schedules. Additionally, the opening of private clinics encourages healthy market competition. This rivalry promotes innovation in patient services, technology adoption, and treatment approaches, which eventually raises standards of care for everyone in the sector.

Furthermore, private institutions frequently include the newest dialysis equipment, cutting-edge medical staff, and sophisticated technology, guaranteeing successful and efficient treatments. Patient referrals and market expansion are further fuelled by this high standard of service, which fosters confidence between referring doctors and patients. By offering alternatives to public healthcare systems, private dialysis clinics help ease the strain on those in need of dialysis treatments. This is especially important in areas where public resources are few since private facilities can relieve some of the pressure on the healthcare system.

Enhanced Haemodialysis Centre Accessibility Will Spur Market Growth

There's a growing need for efficient renal facilities with lower wait times due to the increasing number of patients needing dialysis, particularly in low- and middle-income nations. Nephrologists are becoming more and more common in developed nations, which has led to an increase in the number of renal care institutions. Furthermore, investors are concentrating more on expanding the network of renal treatment facilities in nations like China, Mexico, and India in order to meet the rising need for renal care in emerging economies. It is anticipated that this will boost market revenue in the upcoming years. The number of people visiting these clinics is rising as a result of the economical care that is provided in these nations.  For instance, Life Healthcare declared in May 2023 that it has taken over the management of Fresenius Medical Care's renal dialysis facilities in Southern Africa. The company expanded its services in the area by gaining operational rights to 51 renal dialysis clinics through this acquisition.

North America Dialysis Market

In 2023, North America held a sizable portion of the market. Throughout the projection period, the region is anticipated to continue to dominate the market. The elevated incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States and Canada, together with higher treatment rates in these countries, are the primary factors expected to encoyrage the growth of the regional market during the projection period. The need for dialysis services and supplies is predicted to rise in the US due to the increase in coronavirus infections, which can occasionally lead to renal failure. For instance, in September 2021, an article from the U.S. NIH (National Institutes of Health) stated that 1 in 7 adults in the country, or approximately 786,000 people, had end-stage renal disease.

Furthermore, the use of dialysis treatments is increased by government programs, reimbursement guidelines, and awareness efforts that further encourage early detection and treatment for kidney-related problems. Furthermore, the development and adoption of cutting-edge dialysis technologies are aided by the concentration of top dialysis firms and medical research institutes in North America

Global Dialysis Company Analysis

The key players in the dialysis industry are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, DaVita Inc., Fresenius Medical Care AG & Co. KGaA, JMS Co. Ltd. and Medtronic Plc.

Global Dialysis Company News

May 2023 - Global Medical Supply Chain LLC and Rockwell Medical, Inc. worked together to distribute Rockwell's hemodialysis concentrate products in the United Arab Emirates.

April 2023 - The goal of Fresenius Medical Care AG & Co. KGaA's increased partnership with DocGo, Inc. was to obtain data insights from the company's chronic condition management solution.

April 2022 - The FDA in the United States granted clearance (510(k)) to Fresenius Medical Care North America for its VersiPD Cycler System, a mobile automated peritoneal dialysis device.

March 2022 - Ten dialysis machines were installed when the Sathyalok free dialysis clinic opened. The Rotary Club of Chennai provided funding for the launch. In 2022, 18,000 patients received free dialysis from this clinic.

Type – Market breakup in 2 viewpoints:

1. Peritoneal Dialysis
2. Hemodialysis

Product & Services – Market breakup in 4 viewpoints:

1. Services
2. Equipment
3. Consumables
4. Drugs

End User – Market breakup in 2 viewpoints:

1. Home Dialysis
2. In Center Dialysis

Countries – Market breakup in 25 viewpoints:

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• the Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

All the key players have been covered from 5 Viewpoints:

• Business Overview
• Key Persons
• Product Portfolio
• Recent Development
• Financial Insights

Key Players Analysis:

1. Asahi Kasei Corporation
2. Braun Melsungen AG
3. Baxter International Inc.
4. Becton Dickinson and Company
5. DaVita Inc.
6. Fresenius Medical Care AG & Co. KGaA
7. JMS Co. Ltd.
8. Medtronic Plc.

Report Details: